Non-invasive characterization of the area-at-risk using magnetic resonance imaging in chronic ischaemia

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 166-174

  Wu, Ming ^a   Dhooge, Jan ^a   Ganame, Javier ^a,b   Ferferieva, Vesselina ^a   Sipido, Karin R ^a   Maes, Frederik ^c   Dymarkowski, Steven ^b   Bogaert, Jan ^b   Rademakers, Frank E ^a   Claus, Piet ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Katholieke Universiteit Leuven   (Belgium)

Author keywords

Ischaemia; Magnetic resonance imaging; Myocardial contraction; Myocardial infarction; Perfusion

Indexed keywords

ADENOSINE; COPPER; DOBUTAMINE; EVANS BLUE; MICROSPHERE;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG MEGADOSE; FERMI MODEL; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART PERFUSION; IMPLANTATION; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCESS MODEL; QUANTITATIVE STRESS PERFUSION MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; SHAM PROCEDURE; STAINING; SWINE;

ANIMALS; CARDIOTONIC AGENTS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; DOBUTAMINE; FEMALE; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; REGIONAL BLOOD FLOW; SUS SCROFA;

EID: 78650423576     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq257     Document Type: Article

References (23)

1. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF Jr et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113: 1865-1870.
2. Fallavollita JA, Logue M, Canty JM Jr. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. J Am Coll Cardiol 2001;37:1989-1995.
3. Bolukoglu H, Liedtke AJ, Nellis SH, Eggleston AM, Subramanian R, Renstrom B. An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol 1992;263:H20-H29.
4. St Louis JD, Hughes GC, Kypson AP, DeGrado TR, Donovan CL, Coleman RE et al. An experimental model of chronic myocardial hibernation. Ann Thorac Surg 2000;69: 1351-1357.
5. Weidemann F, Dommke C, Bijnens B, Claus P, D'hooge J, Mertens P et al. Defining the transmurality of a chronic myocardial infarction by ultrasonic strain-rate imaging: implications for identifying intramural viability: an experimental study. Circulation 2003;107:883-888.
6. Fallavollita JA, Malm BJ, Canty JM Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003;92:48-55.
7. Christian TF, Rettmann DW, Aletras AH, Liao SL, Taylor JL, Balaban RS et al. Absolute myocardial perfusion in canines measured by using dual-bolus first-pass MR imaging. Radiology 2004;232:677-684.
8. Hsu LY, Rhoads KL, Holly JE, Kellman P, Aletras AH, Arai AE. Quantitative myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass MRI technique in humans. J Magn Reson Imaging 2006;23:315-322.
9. Brix G, Lucht R, Griebel J. Tracer kinetic analysis of signal time series from dynamic contrast-enhanced MR imaging. Biomed Tech (Berl) 2006;51:325-330.
10. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
11. 13N-ammonia and validation with microspheres in a pig model. Circulation 2009;119:2333-2342.
12. Lautamäki R, Schuleri KH, Sasano T, Javadi MS, Youssef A, Merill J et al. Integration of infarct size, tissue perfusion, and metabolism by hybrid cardiac positron emission tomography/computed tomography. Evaluation in a porcine model of myocardial infarction. Circ Cardiovasc Imaging 2009;2:299-305.
13. Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Nakyen S, Thanapiboonpol P, Yindeengam A et al. Myocardial perfusion cardiac magnetic resonance for the diagnosis of coronary artery disease: do we need rest images? Int J Cardiovasc Imaging 2009; 25(Suppl. 1):139-148.
14. Saeed M, Wendland MF, Szolar D, Sakuma H, Geschwind JF, Globits S et al. Quantification of the extent of area at risk with fast contrast-enhanced magnetic resonance imaging in experimental coronary artery stenosis. Am Heart J 1996;132:921-932.
15. Muehling OM, Jerosch-Herold M, Panse P, Zenovich A, Wilson BV, Wilson RF et al. Regional heterogeneity of myocardial perfusion in healthy human myocardium: assessment with magnetic resonance perfusion imaging. J Cardiovasc Magn Reson 2004;6:499-507.
16. Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151-161.
17. 2+ release in myocytes from chronically ischemic myocardium. Circ Res 2008;102:338-346.
18. Rosen BD, Lima JA, Nasir K, Edvardsen T, Folsom AR, Lai S et al. Lower myocardial perfusion reserve is associated with decreased regional left ventricular function in asymptomatic participants of the multi-ethnic study of atherosclerosis. Circulation 2006;114:289-297.
19. Firoozan S, Wei K, Linka A, Skyba D, Goodman NC, Kaul S. A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations. Am J Physiol 1999;276:H446-H455.
20. Iyer V, Canty JM Jr. Regional desensitization of beta-adrenergic receptor signaling in swine with chronic hibernating myocardium. Circ Res 2005;97:789-795.
21. Al-Saadi N, Gross M, Paetsch I, Schnackenburg B, Bornstedt A, Fleck E et al. Dobu-tamine induced myocardial perfusion reserve index with cardiovascular MR in patients with coronary artery disease. J Cardiovasc Magn Reson 2002;4:471-480.
22. Bartunek J, Wijns W, Heyndrickx GR, de Bruyne B. Effects of dobutamine on coronary stenosis physiology and morphology: comparison with intracoronary adenosine. Circulation 1999;100:243-249.
23. Skopicki HA, Abraham SA, Picard MH, Alpert NM, Fischman AJ, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation 1997;96:3346-3352.